Geert Cauwenbergh
2016
In 2016, Geert Cauwenbergh earned a total compensation of $638.5K as President, Chief Executive Officer and acting Chief Financial Officer at RXi Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $197,600 |
|---|---|
| Option Awards | $26,602 |
| Salary | $413,723 |
| Other | $624 |
| Total | $638,549 |
Cauwenbergh received $413.7K in salary, accounting for 65% of the total pay in 2016.
Cauwenbergh also received $197.6K in non-equity incentive plan, $26.6K in option awards and $624 in other compensation.
Rankings
In 2016, Geert Cauwenbergh's compensation ranked 10,282nd out of 14,075 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 26.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,282 out of 14,075 | 27th |
Division Manufacturing | 3,974 out of 5,489 | 28th |
Major group Chemicals And Allied Products | 1,400 out of 1,895 | 26th |
Industry group Drugs | 1,119 out of 1,538 | 27th |
Industry Pharmaceutical Preparations | 876 out of 1,176 | 26th |
Source: SEC filing on April 27, 2017.
Cauwenbergh's colleagues
We found one more compensation record of an executive who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2016.
2016
Pamela Pavco
RXi Pharmaceuticals